Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
April 24, 2024 17:25 ET
|
Avid Bioservices, Inc
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion...
Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases
April 24, 2024 07:00 ET
|
Biolojic Design
Nektar Therapeutics Has Exercised Its License Option to Develop Biolojic Design's AI-Designed Antibody Targeting TNFR2 in Immunology
Biologics Market Size Expected to Reach USD 845.78 Billion by 2033
March 12, 2024 11:20 ET
|
Precedence Research
Ottawa, March 12, 2024 (GLOBE NEWSWIRE) -- The global biologics market size was valued at USD 419.07 billion in 2023 and is projected to surpass around USD 698.17 billion by 2031, a study published...
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
March 06, 2024 23:58 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing...
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
March 06, 2024 16:32 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it...
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
March 06, 2024 16:31 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Biologics Contract Development & Manufacturing Organization Market revenue to hit USD 39 Billion by 2036, says Research Nester
February 08, 2024 05:30 ET
|
Research Nester
New York, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The global biologics contract development & manufacturing organization (CDMO) market size is projected to grow at a CAGR of over ~12% from 2024 to...
Prefilled Syringes Market Size to Surpass USD 72.9 Billion by 2033 Owing to the Increasing Prevalence of Chronic Diseases
January 22, 2024 13:30 ET
|
Market.Us
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Prefilled Syringes Market size is forecasted to exceed US$ 72.9 Billion by 2033, with a promising CAGR of 12.3% from...
Biologics Market Size Estimated to Reach USD 620.31 Billion by 2032
January 08, 2024 11:15 ET
|
Precedence Research
Ottawa, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The global biologics market size accounted for USD 387.73 billion in 2024, grew to USD 409.84 billion in 2025 and the industry is expanding at a CAGR of 6%...
Biologics Market Growth CAGR 6.9% During 2023-2032 | Xcellent Insights
January 03, 2024 03:00 ET
|
XCELLENT INSIGHTS LLP
Pune, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The global biologics market is expected to register a rapid revenue CAGR of 6.9% during the forecast period. This growth can be attributed to factors such...